Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 266

    1.

    Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction.

    Ganz DA, Kuntz KM, Jacobson GA, Avorn J.

    Ann Intern Med. 2000 May 16;132(10):780-7. Erratum in: Ann Intern Med 2002 Apr 16;136(8):635. PMID: 10819700 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.

    Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S.

    Circulation. 2007 May 8;115(18):2398-409. Epub 2007 Apr 23.PMID: 17452609 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

    Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC.

    Ann Intern Med. 2000 May 16;132(10):769-79.PMID: 10819699 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A systematic review and economic evaluation of statins for the prevention of coronary events.

    Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

    Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

    Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK.

    Ann Intern Med. 2001 Nov 20;135(10):870-83.PMID: 11712877 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

    Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L.

    Ann Intern Med. 2009 Feb 17;150(4):243-54.PMID: 19221376 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.

    Pignone M, Earnshaw S, Tice JA, Pletcher MJ.

    Ann Intern Med. 2006 Mar 7;144(5):326-36.PMID: 16520473 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    Hornberger J, Robertus K.

    Ann Intern Med. 2006 Sep 5;145(5):317-25.PMID: 16954357 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.

    Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH.

    Circulation. 2008 Mar 11;117(10):1261-8. Epub 2008 Feb 19.PMID: 18285564 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.

    Peura P, Martikainen J, Soini E, Hallinen T, Niskanen L.

    Curr Med Res Opin. 2008 Jun;24(6):1823-32. Epub 2008 May 15.PMID: 18485270 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cost-effectiveness of diagnostic strategies for patients with chest pain.

    Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS.

    Ann Intern Med. 1999 May 4;130(9):709-18.PMID: 10357689 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cost-effectiveness of captopril therapy after myocardial infarction.

    Tsevat J, Duke D, Goldman L, Pfeffer MA, Lamas GA, Soukup JR, Kuntz KM, Lee TH.

    J Am Coll Cardiol. 1995 Oct;26(4):914-9.PMID: 7560617 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

    Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

    Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.PMID: 18485273 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis.

    Schleinitz MD, Weiss JP, Owens DK.

    Am J Med. 2004 Jun 15;116(12):797-806.PMID: 15178495 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data